Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 451 AL 465

Advanced analytical methodologies in Alzheimer's disease drug discovery

De Simone A, Naldi M, Tedesco D, Bartolini M, Davani L, Andrisano V.

J Pharm Biomed Anal. 2020 Jan 30;178:112899. doi: 10.1016/j.jpba.2019.112899. Epub 2019 Sep 29.

Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease

Vander Zanden CM, Chi EY.

J Pharm Sci. 2020 Jan;109(1):68-73. doi: 10.1016/j.xphs.2019.10.024. Epub 2019 Oct 21.

Considerations for future tau-targeted therapeutics: can they deliver?

Noble W, Jimenez-Sanchez M, Perez-Nievas BG, Hanger DP.

Expert Opin Drug Discov. 2020 Mar;15(3):265-267. doi: 10.1080/17460441.2020.1685977. Epub 2019 Oct 29.

Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease

Uddin MS, Kabir MT, Tewari D, Mathew B, Aleya L.

Sci Total Environ. 2020 Jan 15;700:134836. doi: 10.1016/j.scitotenv.2019.134836. Epub 2019 Oct 21.

Neural stem cell therapy for neurovascular injury in Alzheimer's disease

Boese AC, Hamblin MH, Lee JP.

Exp Neurol. 2020 Feb;324:113112. doi: 10.1016/j.expneurol.2019.113112. Epub 2019 Nov 12.

Facing the complexity of Alzheimer's disease

Dallemagne P, Rochais C.

Future Med Chem. 2020 Feb;12(3):175-177. doi: 10.4155/fmc-2019-0310. Epub 2019 Nov 21.

Autophagy induction in the treatment of Alzheimer's disease

Schmukler E, Pinkas-Kramarski R.

Drug Dev Res. 2020 Apr;81(2):184-193. doi: 10.1002/ddr.21605. Epub 2019 Nov 29.

PPARα serves as a new receptor of aspirin for neuroprotection

Patel D, Roy A, Pahan K.

J Neurosci Res. 2020 Apr;98(4):626-631. doi: 10.1002/jnr.24561. Epub 2019 Dec 3.

Age related neurodegenerative Alzheimer's disease: Usage of traditional herbs in therapeutics

Singh A, Agarwal S, Singh S.

Neurosci Lett. 2020 Jan 19;717:134679. doi: 10.1016/j.neulet.2019.134679. Epub 2019 Dec 6.

Natural products and their derivatives as multifunctional ligands against Alzheimer's disease

Patil P, Thakur A, Sharma A, Flora SJS.

Drug Dev Res. 2020 Apr;81(2):165-183. doi: 10.1002/ddr.21587. Epub 2019 Aug 20.

Mammalian phospholipase D: Function, and therapeutics

McDermott MI, Wang Y, Wakelam MJO, Bankaitis VA.

Prog Lipid Res. 2020 Apr;78:101018. doi: 10.1016/j.plipres.2019.101018. Epub 2019 Dec 9.

New Therapeutic Targets for Brain Function and Disease

van Lier JE.

J Med Chem. 2020 Jun 25;63(12):6474-6476. doi: 10.1021/acs.jmedchem.9b01947. Epub 2019 Dec 17.

Potassium channels in the neuronal homeostasis and neurodegenerative pathways underlying Alzheimer's disease: An update

Villa C, Suphesiz H, Combi R, Akyuz E.

Mech Ageing Dev. 2020 Jan;185:111197. doi: 10.1016/j.mad.2019.111197. Epub 2019 Dec 17.

Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers

Gopalan D, Pandey A, Udupa N, Mutalik S.

J Control Release. 2020 Mar 10;319:183-200. doi: 10.1016/j.jconrel.2019.12.034. Epub 2019 Dec 19.

Oxidative stress in alzheimer's disease: A review on emergent natural polyphenolic therapeutics

Cassidy L, Fernandez F, Johnson JB, Naiker M, Owoola AG, Broszczak DA.

Complement Ther Med. 2020 Mar;49:102294. doi: 10.1016/j.ctim.2019.102294. Epub 2019 Dec 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias